PL328081A1 - Peptidic inhibitors of haematoblast proliferation - Google Patents

Peptidic inhibitors of haematoblast proliferation

Info

Publication number
PL328081A1
PL328081A1 PL97328081A PL32808197A PL328081A1 PL 328081 A1 PL328081 A1 PL 328081A1 PL 97328081 A PL97328081 A PL 97328081A PL 32808197 A PL32808197 A PL 32808197A PL 328081 A1 PL328081 A1 PL 328081A1
Authority
PL
Poland
Prior art keywords
haematoblast
proliferation
peptidic inhibitors
peptidic
inhibitors
Prior art date
Application number
PL97328081A
Inventor
Josiane Thierry
Joanna Wdzieczak-Bakala
Pierre Potier
Maryse Lenfant
Catherine Grillon
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of PL328081A1 publication Critical patent/PL328081A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
PL97328081A 1996-02-01 1997-01-31 Peptidic inhibitors of haematoblast proliferation PL328081A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59536196A 1996-02-01 1996-02-01
US75451196A 1996-11-19 1996-11-19

Publications (1)

Publication Number Publication Date
PL328081A1 true PL328081A1 (en) 1999-01-04

Family

ID=27082249

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97328081A PL328081A1 (en) 1996-02-01 1997-01-31 Peptidic inhibitors of haematoblast proliferation

Country Status (7)

Country Link
EP (1) EP0877753A1 (en)
JP (1) JP2002515864A (en)
AU (1) AU721261B2 (en)
CA (1) CA2244673A1 (en)
IL (1) IL125509A0 (en)
PL (1) PL328081A1 (en)
WO (1) WO1997028183A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814076B1 (en) 2000-09-21 2002-12-20 Centre Nat Rech Scient ANGIOGENIC AGENT AND USES THEREOF
FR2872040B1 (en) 2004-06-23 2006-09-22 Centre Nat Rech Scient Cnrse COSMETIC USE OF AT LEAST ONE AC-N-SER-ASP-LYS-PRO NATURAL TETRAPEPTIC OR ONE OF ITS ANALOGUES AS AN ANTI-AGING AND RESTRUCTURING AGENT OF THE SKIN
FR2882256B1 (en) 2005-02-18 2007-05-25 Centre Nat Rech Scient COSMETIC USE OF AT LEAST ONE AC-N-SER-ASP-LYS-PRO NATURAL TETRAPEPTIDE OR ONE OF ITS ANALOGUES AS AN AGENT TO SLOW DOWN THE FALL OF HAIR AND / OR STIMULATE THEIR GROWTH
KR101335203B1 (en) * 2010-03-26 2013-11-29 숙명여자대학교산학협력단 Peptides for Promotion of Angiogenesis and the use thereof
WO2014078787A1 (en) 2012-11-19 2014-05-22 Wellstat Therapeutics Corporation Stem cell mobilization and tissue repair and regeneration
FR3120794B1 (en) 2021-03-16 2023-11-24 Rpm Dermatologie Composition for injection comprising a peptide conjugate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601678B1 (en) * 1986-07-18 1989-11-24 Inst Nat Sante Rech Med PEPTIDES COMPRISING THE SERYL-ASPARTYL-LYSYL-PROLYLE SEQUENCE, PROCESS FOR THE EXTRACTION OF THE CORRESPONDING TETRAPEPTIDE, AND APPLICATIONS, IN PARTICULAR FOR THE PROTECTION OF THE BONE MARROW DURING CHEMOTHERAPY ANTI-CANCER TREATMENTS
DE4224509C2 (en) * 1992-07-24 1995-04-20 Ruhenstroth Bauer Gerhard Prof Active ingredient for inhibiting the proliferation rate of liver cells

Also Published As

Publication number Publication date
IL125509A0 (en) 1999-03-12
EP0877753A1 (en) 1998-11-18
WO1997028183A1 (en) 1997-08-07
JP2002515864A (en) 2002-05-28
CA2244673A1 (en) 1997-08-07
AU1807597A (en) 1997-08-22
AU721261B2 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
AP9701054A0 (en) Inhibitors of cycteine protease
PL331254A1 (en) Phosphonianic inhibitors of matrix metaloproteases
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
EP1009415A4 (en) INHIBITORS OF $g(b)-LACTAMASES AND USES THEREFOR
ZA97327B (en) Substituted histidine inhibitors of protein farnesyltransferase
PL322549A1 (en) Inhibitors of proteinous farnesiltransferase
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
PL327569A1 (en) Promedications of thrombosin inhibitors
HUP9700602A3 (en) New inhibitors of bone-resorption and vitronectine-receptor-antagonists
PL328868A1 (en) Inhibitors of pharnesil protein transferase
EP0934404A4 (en) Inhibition of proliferation of cells
PL331856A1 (en) Heterocyclic inhibitors of metaloprotease
GB9715519D0 (en) Variety of different sources
PL333434A1 (en) Aminoguanidines and alkoxyguanidines as inhibitors of proteases
PL328307A1 (en) Serinic protease inhibitors
PL331920A1 (en) Spirocyclic inhibitors of metaloproteases
PL328665A1 (en) Inhibitors of serinic protease
PL331803A1 (en) Bidonoric metaloprotease inhibitors
PL334975A1 (en) Application of gasto-intestinal lipase inhibitors
EP0894496A4 (en) Neovascularization inhibitor
PL328875A1 (en) Serinic protease inhibitors
PL328223A1 (en) Aspartil protease inhibitors
ZA983065B (en) Inhibitors of protein farnesyltranferase
ZA9710989B (en) Polyprolyl inhibitors of cyclophilin
PL328081A1 (en) Peptidic inhibitors of haematoblast proliferation